Last10K.com

Medicinova Inc (MNOV) SEC Filing 8-K Material Event for the period ending Friday, January 29, 2021

Medicinova Inc

HISTORY TOOLS
CIK: 1853928 Ticker: MNOV

View differences made from one to another to evaluate Medicinova Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Medicinova Inc.

Continue

Assess how Medicinova Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Medicinova Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information

Material Contracts, Statements, Certifications & more

Medicinova Inc provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: MNOV
CIK: 1226616
Form Type: 8-K Corporate News
Accession Number: 0001193125-21-023589
Submitted to the SEC: Mon Feb 01 2021 6:32:01 AM EST
Accepted by the SEC: Mon Feb 01 2021
Period: Friday, January 29, 2021
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events
  3. Unregistered Sales

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mnov/0001193125-21-023589.htm